| Date | Action | Conf | Host / episode | Summary | 7d | 30d | 90d |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | HOLD | MEDIUM | Rob Black Show Stocks Little Changed As Traders Watch Yield Moves |
Bank of America raised Johnson & Johnson's price target while remaining neutral, supported by higher projected psoriasis-drug sales. [audio] | — | — | — |
| 2026-09-10 | WATCH | MEDIUM | Rob Black Show Stocks Dropped After Oil Prices Topped A Hundred A Barrel |
Rob singles out Johnson & Johnson's strong pipeline as part of healthcare's appeal for quality earnings and lower perceived risk than AI. [audio] | +1.5% | — | — |
| 2026-09-01 | MENTIONED | LOW | Rob Black Show Rough Start To September |
Cited as one of the more in-vogue drug makers alongside Eli Lilly. [audio] | -0.8% | — | — |
| 2026-08-18 | MENTIONED | HIGH | Rob Black Show Afternoon podcast 8-18-26 |
Johnson & Johnson rose 3.3% on a defensive day for the market. [audio] | +1.2% | +0.2% | — |
| 2026-08-13 | MENTIONED | LOW | Rob Black Show More Encouraging Inflation Data |
Rob listed Johnson & Johnson among the medtech and pharma names investors might choose for exposure. [audio] | +2.0% | +1.8% | — |
| 2026-07-28 | MENTIONED | MEDIUM | Rob Black Show Afternoon podcast 7-28-26 |
Johnson & Johnson is mentioned as being up 1% after settling thousands of lawsuits related to talc powder. [audio] | -4.4% | +0.1% | — |
| 2026-07-28 | MENTIONED | MEDIUM | Rob Black Show Dow Rises But Semiconductors Slide |
Johnson & Johnson is up after announcing a $5.5 billion ovarian talc litigation resolution. [audio] | -4.4% | +0.1% | — |
| 2026-07-15 | HOLD | HIGH | Rob Black Show Stocks Rise On Big Tech Gains |
Johnson & Johnson trading flat after solid Q2 earnings and raised guidance, with strong innovative medicine sales. [audio] | +3.5% | +5.4% | — |
| 2026-07-13 | MENTIONED | LOW | Rob Black Show Oil Gains After Trump Reimposes Blockade |
Johnson & Johnson is referenced as reporting earnings this week. [audio] | -3.5% | +1.2% | — |
| 2026-07-10 | BUY | HIGH | Rob Black Show Rules For Financial Freedom |
Host lists Johnson & Johnson as a favorite brand and investment for its recurring revenue and strong brand. [audio] | -1.5% | +0.9% | — |
| 2026-07-09 | MENTIONED | LOW | Rob Black Show Stocks Rose Supported By Jump In Semiconductors |
Johnson & Johnson is near all-time highs, mentioned among drug makers. [audio] | -3.5% | +0.1% | — |
| 2026-06-29 | BUY | HIGH | Rob Black Show Afternoon podcast 6-29-26 |
Johnson & Johnson traded at all-time highs; host wants to get more money into JNJ for dividend stability. [audio] | +0.3% | +2.7% | +5.4% |
| 2026-06-24 | MENTIONED | LOW | Rob Black Show Oil Prices Fall Four Percent |
Johnson & Johnson mentioned as a mainstay stock that was positive during market rotation. [audio] | +5.4% | +9.3% | +12.2% |
| 2026-06-23 | MENTIONED | LOW | Rob Black Show Afternoon podcast 6-23-26 |
Johnson & Johnson is mentioned as a defensive stock that moved higher. [audio] | +6.2% | +8.4% | +13.3% |
| 2026-06-22 | MENTIONED | LOW | Rob Black Show Declines In Technology Stocks |
Johnson & Johnson's Trimvia competes with AbbVie's SkyRizzy. [audio] | +11.8% | +10.5% | +17.3% |
| 2026-06-09 | MENTIONED | LOW | Rob Black Show Chip Stocks Lost Momentum |
Johnson & Johnson is mentioned as an outperformer in healthcare sector. [audio] | -0.8% | +9.3% | +16.7% |
| 2026-05-29 | BUY | MEDIUM | Rob Black Show Thinking About A Shopping List |
The host recommends buying Johnson & Johnson, citing a low P/E ratio and the potential for AI-driven growth. [audio] | +3.3% | +13.0% | +18.5% |
| 2026-05-19 | MENTIONED | LOW | Rob Black Show Afternoon podcast 5-19-26 |
Host lists Johnson & Johnson as one of the top 10 stocks today. [audio] | +0.7% | -0.1% | +14.7% |
| 2026-05-19 | MENTIONED | MEDIUM | Rob Black Show Stocks Slide Under Pressure From Higher Rates |
The host recounts a story about an ex-nun client who invested in Johnson & Johnson when the birth control pill was invented, noting that the stock did very well. [audio] | +0.7% | -0.1% | +14.7% |
| 2026-05-18 | WATCH | LOW | Rob Black Show Afternoon podcast 5-18-26 |
Johnson & Johnson is listed as one of the top 10 companies by profit share in the S&P 500 historically. [audio] | +2.4% | +2.9% | +14.4% |
| 2026-05-13 | BUY | HIGH | Rob Black Show Mixed Markets As Inflation Jumps |
Upgraded to buy at Lyrink with a $265 price target; host considers it a stock to buy for retirement stability. [audio] | -0.5% | +5.1% | +13.4% |